Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes.
about
Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical IntegrationAngiogenic factors in preeclampsia: potential for diagnosis and treatmentAngiogenic factors in diagnosis, management, and research in preeclampsia.Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review.Proteinuria as a predictor of complications of pre-eclampsia.Is massive proteinuria associated with maternal and fetal morbidities in preeclampsia?How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis.Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review.Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsiaPreeclampsia is associated with increased maternal body weight in a northeastern Brazilian population.Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsiaAngiogenic factors and the risk of adverse outcomes in women with suspected preeclampsiaMaternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.Pre-eclampsia, severe pre-eclampsia and hemolysis, elevated liver enzymes and low platelets syndrome: what is new?Pre-eclampsia: an update.Towards biomarker-based tests that can facilitate decisions about prevention and management of preeclampsia in low-resource settings.SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014.Prediction of progression to severe disease in women with late preterm hypertensive disorders of pregnancy.A Prospective Study of Placental Growth Factor Assay as a Novel Biomarker in Predicting Early-Onset Preeclampsia in High-Risk Patients.Prediction of Adverse Maternal Outcomes in Preeclampsia Using a Risk Prediction ModelPreeclampsia and the kidney: footprints in the urine.Preeclamptic angina--a pathognomonic symptom of preeclampsia.Risk indicators for eclampsia in gestational hypertension or mild preeclampsia at term.Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia.
P2860
Q26796661-E26CDD65-B2AF-4CB0-B396-14E0C719CD41Q26825774-A11DF02E-F3A5-4E69-8BA4-290BD036D067Q27692060-FA38B7F3-0FA2-4D2B-8426-C9E1F6A13524Q33327641-A36BA774-C389-44C4-B770-5213669113E8Q33421544-C83EA2DD-4DBF-4C73-9285-DA79C8A59176Q33711849-2D9CC44B-0D7A-4DC3-B479-10C20648A1CAQ33830857-965A6BF2-B082-4D2C-AB59-AB5EF35E5DD5Q33830864-E6A396F9-A64D-411F-A171-76A4C945027CQ34119026-F710A0E4-0AEA-48EE-B37B-7F12C2260E40Q34461130-673EDDF0-0F5A-4F72-91B6-E65F19467072Q34508609-C3E91315-E681-4AF2-99DA-5330406BF05CQ35538277-86DFA84E-66FB-43EF-B3FF-03E89B45CA9CQ35871381-D562B917-FCE8-4DBF-9819-6666288A80A0Q36062460-DA6739B5-1F01-4CE3-9578-199EABCCAAC9Q37098433-C73942CC-2FEA-47DE-9EA4-A914C3B42297Q37924287-46F3FC0B-A07A-4BEE-B2AA-3A1BD7080CC6Q38219228-6646A954-99DF-46A2-B9DF-01334F60E21BQ38493639-67120353-38DB-4814-9D5E-173EE91A812DQ38594110-62534911-8D93-45A6-A56B-7F5E982D5903Q39238730-B50C0417-19FA-4663-8705-6F38029FA4CFQ41650909-59C72EC0-2834-4E8F-8435-88CB87FED5F7Q41650917-90905BAE-D0C6-461E-A22F-A25F5CDE196BQ42773699-228D4387-6F51-4E04-B76F-68FA1E9E37D6Q46329026-5558FDDD-A278-47E0-B1D8-29B7F404FBC0Q50669572-B6323A09-093C-4F03-9D38-9C1FBE5C8D3FQ54399385-5564F4D6-8E2F-40AD-94FA-7CE99995B493
P2860
Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Current CHS and NHBPEP criteri ...... aternal or perinatal outcomes.
@ast
Current CHS and NHBPEP criteri ...... aternal or perinatal outcomes.
@en
type
label
Current CHS and NHBPEP criteri ...... aternal or perinatal outcomes.
@ast
Current CHS and NHBPEP criteri ...... aternal or perinatal outcomes.
@en
prefLabel
Current CHS and NHBPEP criteri ...... aternal or perinatal outcomes.
@ast
Current CHS and NHBPEP criteri ...... aternal or perinatal outcomes.
@en
P2093
P2860
P1476
Current CHS and NHBPEP criteri ...... aternal or perinatal outcomes.
@en
P2093
J A Russell
J J Walker
J M Moutquin
K R Walley
M J Douglas
P2860
P304
P356
10.1080/10641950701521742
P577
2007-01-01T00:00:00Z